Virtual Biotech Company Puts 37,000 AI Agents to Work on Drug Discovery
5 Articles
5 Articles
Developing a new drug can take years and cost hundreds of millions of dollars. Learn how AI-powered virtual biotechnology is using AI to accelerate drug discovery. A virtual biotechnology company is using 37,000 AI agents in drug discovery. Developing a new drug can take years and cost hundreds of millions of dollars, and even then… The article "Virtual Biotechnology Company Uses 37,000 AI Agents in Drug Discovery" first appeared on Battery Rob…
An ‘AI pharmaceutical company’ has emerged where 37,000 AI researchers, who neither eat nor sleep, search for new drug candidates 24 hours a day. It implements the research organization of a pharmaceutical company using AI, ranging from the Chief Scientific Officer (CSO) directing the research to researchers in various fields.
AI discovers drugs: a system of 37,000 agents identifies a candidate against lung cancer, according to Science. La entrada AI discovers drug against lung cancer: the finding that accelerates therapies aparece primero en Merca2.
Imagine a pharmaceutical company without laboratories, test pieces and payroll. Just code and crazy ambition. It's the spectacular project led by Stanford researchers who built a completely virtual biotech driven by an army of 37,000 IA "employees".
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
